Rituximab induces clinical stabilization in a patient with fulminant multiple sclerosis not responding to natalizumab: Evidence for disease heterogeneity

V. I. Leussink, H. C. Lehmann, G. Meyer Zu Hörste, H. P. Hartung, O. Stüve, B. C. Kieseier

Research output: Contribution to journalLetterpeer-review

14 Scopus citations

Fingerprint

Dive into the research topics of 'Rituximab induces clinical stabilization in a patient with fulminant multiple sclerosis not responding to natalizumab: Evidence for disease heterogeneity'. Together they form a unique fingerprint.